These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

225 related items for PubMed ID: 2112489

  • 1. Fibroid and myometrial steroid receptors in women treated with gonadotropin-releasing hormone agonist leuprolide acetate.
    Rein MS, Friedman AJ, Stuart JM, MacLaughlin DT.
    Fertil Steril; 1990 Jun; 53(6):1018-23. PubMed ID: 2112489
    [Abstract] [Full Text] [Related]

  • 2. Steroid receptor binding and messenger RNA expression in fibroids from untreated and gonadotrophin-releasing hormone agonist pretreated women.
    Vollenhoven BJ, Pearce P, Herington AC, Healy DL.
    Clin Endocrinol (Oxf); 1994 Apr; 40(4):537-44. PubMed ID: 8187322
    [Abstract] [Full Text] [Related]

  • 3. Decreased prolactin secretion by explant cultures of fibroids from women treated with a gonadotropin-releasing hormone agonist.
    Rein MS, Friedman AJ, Heffner LJ.
    J Clin Endocrinol Metab; 1990 Jun; 70(6):1554-8. PubMed ID: 2112150
    [Abstract] [Full Text] [Related]

  • 4. Sex steroid receptors in human myometrium and fibroids: changes during the menstrual cycle and gonadotropin-releasing hormone treatment.
    Englund K, Blanck A, Gustavsson I, Lundkvist U, Sjöblom P, Norgren A, Lindblom B.
    J Clin Endocrinol Metab; 1998 Nov; 83(11):4092-6. PubMed ID: 9814497
    [Abstract] [Full Text] [Related]

  • 5. The secretion of insulin-like growth factors I and II by explant cultures of fibroids and myometrium from women treated with a gonadotropin-releasing hormone agonist.
    Rein MS, Friedman AJ, Pandian MR, Heffner LJ.
    Obstet Gynecol; 1990 Sep; 76(3 Pt 1):388-94. PubMed ID: 2116610
    [Abstract] [Full Text] [Related]

  • 6. Total and unbound cytosolic estrogen and progesterone receptors in myometrium and fibroid after gonadotropin-releasing hormone agonist treatment.
    Fernández-Montolí ME, Díez-Gibert O, Samaniego JM, Balagueró L, Navarro MA.
    Fertil Steril; 1995 Mar; 63(3):522-7. PubMed ID: 7851581
    [Abstract] [Full Text] [Related]

  • 7. Levels of estrogen and progesterone receptors in the myometrium and leiomyoma tissue after suppression of estrogens with gonadotropin releasing hormone analogs.
    van de Ven J, Sprong M, Donker GH, Thijssen JH, Mak-Kregar S, Blankenstein MA.
    Gynecol Endocrinol; 2001 Dec; 15 Suppl 6():61-8. PubMed ID: 12227888
    [Abstract] [Full Text] [Related]

  • 8. Effect of Decapeptyl, an agonistic analog of gonadotropin-releasing hormone on estrogens, estrogen sulfates, and progesterone receptors in leiomyoma and myometrium.
    Pasqualini JR, Cornier E, Grenier J, Vella C, Schatz B, Netter A.
    Fertil Steril; 1990 Jun; 53(6):1012-7. PubMed ID: 2140991
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Cellular proliferation, estrogen receptor, progesterone receptor, and bcl-2 expression in GnRH agonist-treated uterine leiomyomas.
    Vu K, Greenspan DL, Wu TC, Zacur HA, Kurman RJ.
    Hum Pathol; 1998 Apr; 29(4):359-63. PubMed ID: 9563785
    [Abstract] [Full Text] [Related]

  • 13. A prospective, randomized trial of gonadotropin-releasing hormone agonist plus estrogen-progestin or progestin "add-back" regimens for women with leiomyomata uteri.
    Friedman AJ, Daly M, Juneau-Norcross M, Rein MS, Fine C, Gleason R, Leboff M.
    J Clin Endocrinol Metab; 1993 Jun; 76(6):1439-45. PubMed ID: 8501148
    [Abstract] [Full Text] [Related]

  • 14. Treatment of leiomyomata uteri with leuprolide acetate depot: a double-blind, placebo-controlled, multicenter study. The Leuprolide Study Group.
    Friedman AJ, Hoffman DI, Comite F, Browneller RW, Miller JD.
    Obstet Gynecol; 1991 May; 77(5):720-5. PubMed ID: 1901638
    [Abstract] [Full Text] [Related]

  • 15. [Clinical significance of analysis of estrogen and progesterone receptors in human uterine tissues].
    Maleeva A, Milkov V.
    Akush Ginekol (Mosk); 1991 May; (5):55-7. PubMed ID: 1897675
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Expression of progesterone receptors A and B and insulin-like growth factor-I in human myometrium and fibroids after treatment with a gonadotropin-releasing hormone analogue.
    Wu X, Wang H, Englund K, Blanck A, Lindblom B, Sahlin L.
    Fertil Steril; 2002 Nov; 78(5):985-93. PubMed ID: 12413982
    [Abstract] [Full Text] [Related]

  • 18. Gonadotropin-releasing hormone (GnRH) and GnRH receptor gene expression in human myometrium and leiomyomata and the direct action of GnRH analogs on myometrial smooth muscle cells and interaction with ovarian steroids in vitro.
    Chegini N, Rong H, Dou Q, Kipersztok S, Williams RS.
    J Clin Endocrinol Metab; 1996 Sep; 81(9):3215-21. PubMed ID: 8784072
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. The myometrium of postmenopausal women produces prolactin in response to human chorionic gonadotropin and alpha-subunit in vitro.
    Stewart EA, Jain P, Penglase MD, Friedman AJ, Nowak RA.
    Fertil Steril; 1995 Nov; 64(5):972-6. PubMed ID: 7589644
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.